)
)
Oliver Burren
Director Genome Analysis,
AstraZeneca
With over 20 years of impactful experience in genetics, genomics, and data science applied to human disease, I have harnessed my academic interests to drive collaborative drug development initiatives in the pharmaceutical industry for 5 years.
As a manager, I lead a team of genome analysts who work closely with cross-functional teams to apply large-scale proteomics, genomics, and machine learning approaches, driving innovative solutions that enhance drug development.
Sessions
-
Panel Discussion: How Is Translational Proteomics Shaping the Future of Drug Target Discovery?28-Jan-2026Proteogenomics & Translational Omics Stage